Upgrade to SI Premium - Free Trial

DA Davidson Reiterates Buy Rating on Cellebrite (CLBT)

September 15, 2026 9:48 AM
DA Davidson analyst Rudy Kessinger reiterated a Buy rating and $15.00 price target on Cellebrite (NASDAQ: CLBT).The analyst commented, "Yesterday ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments